Rank | Gene Set | Z-score |
---|---|---|
1 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.58654316 |
2 | muscle filament sliding (GO:0030049) | 6.43680980 |
3 | actin-myosin filament sliding (GO:0033275) | 6.43680980 |
4 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.09106335 |
5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.07729793 |
6 | creatine metabolic process (GO:0006600) | 5.51161788 |
7 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.50572433 |
8 | actin-mediated cell contraction (GO:0070252) | 5.35296776 |
9 | NADH metabolic process (GO:0006734) | 5.29849647 |
10 | regulation of relaxation of muscle (GO:1901077) | 5.28682062 |
11 | muscle contraction (GO:0006936) | 5.17739182 |
12 | regulation of the force of heart contraction (GO:0002026) | 4.90916376 |
13 | regulation of skeletal muscle contraction (GO:0014819) | 4.82170756 |
14 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.73911618 |
15 | muscle system process (GO:0003012) | 4.73622664 |
16 | heart process (GO:0003015) | 4.65539077 |
17 | heart contraction (GO:0060047) | 4.65539077 |
18 | striated muscle adaptation (GO:0014888) | 4.51150238 |
19 | carnitine shuttle (GO:0006853) | 4.48250839 |
20 | myofibril assembly (GO:0030239) | 4.47270310 |
21 | respiratory chain complex IV assembly (GO:0008535) | 4.43214285 |
22 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.42747586 |
23 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 4.40969804 |
24 | muscle hypertrophy in response to stress (GO:0003299) | 4.40969804 |
25 | cardiac muscle adaptation (GO:0014887) | 4.40969804 |
26 | facial nerve structural organization (GO:0021612) | 4.37947580 |
27 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.32271844 |
28 | ribosomal small subunit assembly (GO:0000028) | 4.29237299 |
29 | sarcomere organization (GO:0045214) | 4.26387365 |
30 | muscle fiber development (GO:0048747) | 4.23137984 |
31 | skeletal muscle fiber development (GO:0048741) | 4.22997550 |
32 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.21347438 |
33 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.19887297 |
34 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 4.19387993 |
35 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.14964226 |
36 | tricarboxylic acid cycle (GO:0006099) | 4.11102706 |
37 | cardiac myofibril assembly (GO:0055003) | 4.10817579 |
38 | myotube cell development (GO:0014904) | 4.08698556 |
39 | muscle cell cellular homeostasis (GO:0046716) | 4.01074798 |
40 | relaxation of cardiac muscle (GO:0055119) | 3.99883422 |
41 | respiratory electron transport chain (GO:0022904) | 3.97778851 |
42 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.97102082 |
43 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.97102082 |
44 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.95350325 |
45 | lymphoid progenitor cell differentiation (GO:0002320) | 3.94525141 |
46 | regulation of membrane repolarization (GO:0060306) | 3.93742894 |
47 | fatty acid transmembrane transport (GO:1902001) | 3.92775612 |
48 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.92648383 |
49 | skeletal muscle contraction (GO:0003009) | 3.91901746 |
50 | electron transport chain (GO:0022900) | 3.91277006 |
51 | glycogen catabolic process (GO:0005980) | 3.89470100 |
52 | striated muscle cell development (GO:0055002) | 3.89288465 |
53 | regulation of actin filament-based movement (GO:1903115) | 3.88986155 |
54 | plasma membrane repair (GO:0001778) | 3.88513125 |
55 | skeletal muscle tissue development (GO:0007519) | 3.88018637 |
56 | response to caffeine (GO:0031000) | 3.87597852 |
57 | ATP synthesis coupled proton transport (GO:0015986) | 3.86662454 |
58 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.86662454 |
59 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.85697718 |
60 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.85697718 |
61 | quinone biosynthetic process (GO:1901663) | 3.84557640 |
62 | ubiquinone biosynthetic process (GO:0006744) | 3.84557640 |
63 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.82845125 |
64 | DNA deamination (GO:0045006) | 3.82745781 |
65 | cytochrome complex assembly (GO:0017004) | 3.80406173 |
66 | negative regulation of myotube differentiation (GO:0010832) | 3.76336584 |
67 | response to inactivity (GO:0014854) | 3.75943337 |
68 | cell communication involved in cardiac conduction (GO:0086065) | 3.74701202 |
69 | glycogen biosynthetic process (GO:0005978) | 3.71817493 |
70 | glucan biosynthetic process (GO:0009250) | 3.71817493 |
71 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.69923390 |
72 | regulation of ATPase activity (GO:0043462) | 3.68886143 |
73 | regulation of ATP catabolic process (GO:1903289) | 3.68886143 |
74 | striated muscle contraction (GO:0006941) | 3.66309263 |
75 | relaxation of muscle (GO:0090075) | 3.65455687 |
76 | viral transcription (GO:0019083) | 3.65147402 |
77 | glucan catabolic process (GO:0009251) | 3.64216503 |
78 | muscle adaptation (GO:0043500) | 3.64013875 |
79 | regulation of sequestering of triglyceride (GO:0010889) | 3.62909029 |
80 | cardiac muscle contraction (GO:0060048) | 3.61102321 |
81 | regulation of heart rate (GO:0002027) | 3.60147659 |
82 | ribosomal small subunit biogenesis (GO:0042274) | 3.57847482 |
83 | 2-oxoglutarate metabolic process (GO:0006103) | 3.55658113 |
84 | regulation of muscle system process (GO:0090257) | 3.55436504 |
85 | oxidative phosphorylation (GO:0006119) | 3.54545806 |
86 | regulation of cell communication by electrical coupling (GO:0010649) | 3.53886293 |
87 | regulation of muscle contraction (GO:0006937) | 3.53080912 |
88 | regulation of cardiac muscle contraction (GO:0055117) | 3.52927070 |
89 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.52608755 |
90 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.51873900 |
91 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.51873900 |
92 | NADH dehydrogenase complex assembly (GO:0010257) | 3.51873900 |
93 | response to epinephrine (GO:0071871) | 3.48562314 |
94 | actin filament-based movement (GO:0030048) | 3.44936959 |
95 | cell communication by electrical coupling (GO:0010644) | 3.44613893 |
96 | protein complex biogenesis (GO:0070271) | 3.44320612 |
97 | cardiac muscle cell action potential (GO:0086001) | 3.44097275 |
98 | translational termination (GO:0006415) | 3.43507120 |
99 | striated muscle atrophy (GO:0014891) | 3.42043290 |
100 | proteasome assembly (GO:0043248) | 3.41645915 |
101 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.41072123 |
102 | carnitine transmembrane transport (GO:1902603) | 3.41027877 |
103 | cellular polysaccharide catabolic process (GO:0044247) | 3.39989647 |
104 | platelet dense granule organization (GO:0060155) | 3.37892309 |
105 | ubiquinone metabolic process (GO:0006743) | 3.34945190 |
106 | mesonephros development (GO:0001823) | 3.33993741 |
107 | muscle structure development (GO:0061061) | 3.32907844 |
108 | muscle cell development (GO:0055001) | 3.32531799 |
109 | muscle organ development (GO:0007517) | 3.32390795 |
110 | mannosylation (GO:0097502) | 3.31824729 |
111 | polyketide metabolic process (GO:0030638) | 3.31035377 |
112 | doxorubicin metabolic process (GO:0044598) | 3.31035377 |
113 | daunorubicin metabolic process (GO:0044597) | 3.31035377 |
114 | positive regulation of cation channel activity (GO:2001259) | 3.30980734 |
115 | aerobic respiration (GO:0009060) | 3.30591577 |
116 | cellular response to epinephrine stimulus (GO:0071872) | 3.29582930 |
117 | cranial nerve structural organization (GO:0021604) | 3.24082230 |
118 | cardiac muscle cell development (GO:0055013) | 3.23776929 |
119 | regulation of striated muscle contraction (GO:0006942) | 3.21080623 |
120 | GPI anchor biosynthetic process (GO:0006506) | 3.19431191 |
121 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.17073891 |
122 | muscle tissue morphogenesis (GO:0060415) | 3.13137825 |
123 | cotranslational protein targeting to membrane (GO:0006613) | 3.12052682 |
124 | protein targeting to ER (GO:0045047) | 3.08708383 |
125 | short-term memory (GO:0007614) | 3.08200657 |
126 | regulation of sarcomere organization (GO:0060297) | 3.07538007 |
127 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.06646203 |
128 | cardiac cell development (GO:0055006) | 3.04314272 |
129 | cranial nerve morphogenesis (GO:0021602) | 3.03913028 |
130 | regulation of pigment cell differentiation (GO:0050932) | 2.99173883 |
131 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.97392008 |
132 | cardiac muscle hypertrophy (GO:0003300) | 2.97345051 |
133 | protein localization to endoplasmic reticulum (GO:0070972) | 2.94021597 |
134 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.89676196 |
135 | negative regulation of protein localization to cell surface (GO:2000009) | 2.88979831 |
136 | striated muscle hypertrophy (GO:0014897) | 2.87282322 |
137 | pattern specification involved in kidney development (GO:0061004) | 2.86975876 |
138 | postsynaptic membrane organization (GO:0001941) | 2.84280751 |
139 | translational elongation (GO:0006414) | 2.79435023 |
140 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.78221064 |
141 | thyroid gland development (GO:0030878) | 2.77234835 |
142 | negative regulation of metanephros development (GO:0072217) | 2.76360188 |
143 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.76172759 |
144 | adult heart development (GO:0007512) | 2.75481258 |
145 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.70003920 |
146 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 2.67473370 |
147 | response to muscle activity (GO:0014850) | 2.66225105 |
148 | actomyosin structure organization (GO:0031032) | 2.65966395 |
149 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.65028497 |
150 | response to interferon-beta (GO:0035456) | 2.61706188 |
151 | maturation of SSU-rRNA (GO:0030490) | 2.61246163 |
152 | muscle hypertrophy (GO:0014896) | 2.59806426 |
153 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.59520569 |
154 | skeletal muscle adaptation (GO:0043501) | 2.58474034 |
155 | cytidine catabolic process (GO:0006216) | 2.58415027 |
156 | cytidine deamination (GO:0009972) | 2.58415027 |
157 | cytidine metabolic process (GO:0046087) | 2.58415027 |
158 | GPI anchor metabolic process (GO:0006505) | 2.58359743 |
159 | C-terminal protein lipidation (GO:0006501) | 2.57644585 |
160 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.56944811 |
161 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.56944811 |
162 | GTP biosynthetic process (GO:0006183) | 2.56914046 |
163 | regulation of mitochondrial translation (GO:0070129) | 2.55272413 |
Rank | Gene Set | Z-score |
---|---|---|
1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.62567543 |
2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.40452477 |
3 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.12390887 |
4 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.32418680 |
5 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.32418680 |
6 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.23851800 |
7 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 3.12240077 |
8 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.88218905 |
9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.67818273 |
10 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.66233739 |
11 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.65630880 |
12 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.41100660 |
13 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.38674770 |
14 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.38406813 |
15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.36918639 |
16 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.22519052 |
17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.19688634 |
18 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.17532227 |
19 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.15593032 |
20 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.13811979 |
21 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.13596882 |
22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.10346528 |
23 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.06644141 |
24 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.06470410 |
25 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.05084786 |
26 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.00184377 |
27 | VDR_22108803_ChIP-Seq_LS180_Human | 1.95276271 |
28 | GATA1_22025678_ChIP-Seq_K562_Human | 1.94959421 |
29 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.90829038 |
30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.87447807 |
31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82341523 |
32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.81979155 |
33 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71964951 |
34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71246085 |
35 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.68963624 |
36 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.66945767 |
37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.62224352 |
38 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.59736310 |
39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.58981583 |
40 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.55994204 |
41 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.54913627 |
42 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.53593235 |
43 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.53450635 |
44 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.53063415 |
45 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.52520952 |
46 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.51342721 |
47 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.51311118 |
48 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.50711006 |
49 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47547615 |
50 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.43495309 |
51 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.42003978 |
52 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.41519086 |
53 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.40608250 |
54 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.39568584 |
55 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.39403440 |
56 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.39045423 |
57 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.38997052 |
58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.37855356 |
59 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.35474158 |
60 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35031713 |
61 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.33829851 |
62 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32776451 |
63 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.30291070 |
64 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.30290371 |
65 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.28065868 |
66 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.27684391 |
67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25898503 |
68 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.25242956 |
69 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.24988555 |
70 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.23176776 |
71 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.22214057 |
72 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.21387238 |
73 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.20052540 |
74 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.18876099 |
75 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.17959267 |
76 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.17959267 |
77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.17471720 |
78 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.17430114 |
79 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.17338107 |
80 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.16916563 |
81 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.12958033 |
82 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12904081 |
83 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.12377466 |
84 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.11434198 |
85 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.11061353 |
86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.10872976 |
87 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.10708674 |
88 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09269413 |
89 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.08383584 |
90 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.08163007 |
91 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.07984129 |
92 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.06947010 |
93 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06911371 |
94 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.06693255 |
95 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.06121183 |
96 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.05887987 |
97 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.05733322 |
98 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.05674645 |
99 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04360821 |
100 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.02889827 |
101 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.02656074 |
102 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.02459117 |
103 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.02286704 |
104 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.02240812 |
105 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.01414896 |
106 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01027126 |
107 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.99623887 |
108 | ELK1_19687146_ChIP-ChIP_HELA_Human | 0.98773450 |
109 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.98396593 |
110 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.98271040 |
111 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97863273 |
112 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.97645670 |
113 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.96694296 |
114 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.96247335 |
115 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.95760205 |
116 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95309803 |
117 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.95172218 |
118 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95166120 |
119 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95165701 |
120 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.94517719 |
121 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.94283933 |
122 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.94096321 |
123 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.94033470 |
124 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.93374061 |
125 | FUS_26573619_Chip-Seq_HEK293_Human | 0.93259596 |
126 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.93067023 |
127 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.93010329 |
128 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92868676 |
129 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.92295720 |
130 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.92287837 |
131 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.92081063 |
132 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.92043776 |
133 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.91902285 |
134 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.91523610 |
135 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.91216541 |
136 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.90990078 |
137 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.90112601 |
138 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89464430 |
139 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.89156079 |
140 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.89147493 |
141 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.88708699 |
142 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88449757 |
143 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.88436942 |
144 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.88139313 |
145 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87527103 |
146 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87280129 |
147 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.87105816 |
148 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86815762 |
149 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.86254794 |
150 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.85840433 |
151 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.85315705 |
152 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84863470 |
153 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.84764363 |
154 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.84552464 |
155 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.84468411 |
156 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.84188876 |
157 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.84162083 |
158 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.84141521 |
159 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.83589109 |
160 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83314733 |
161 | TBL1_22424771_ChIP-Seq_293T_Human | 0.81852500 |
162 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81593611 |
163 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.81110653 |
164 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.80941804 |
165 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.80267457 |
166 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.79717838 |
167 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79013588 |
168 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.77963257 |
169 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.77631006 |
170 | NFYB_21822215_ChIP-Seq_K562_Human | 0.77621705 |
171 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.77546661 |
172 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.77071926 |
173 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.76033220 |
174 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.75871025 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003646_muscle_fatigue | 4.81725231 |
2 | MP0000749_muscle_degeneration | 4.70338261 |
3 | MP0004145_abnormal_muscle_electrophysio | 4.40091302 |
4 | MP0003136_yellow_coat_color | 3.83517412 |
5 | MP0009379_abnormal_foot_pigmentation | 3.61678490 |
6 | MP0000751_myopathy | 3.46761731 |
7 | MP0005409_darkened_coat_color | 3.35396425 |
8 | MP0001188_hyperpigmentation | 3.06799376 |
9 | MP0004036_abnormal_muscle_relaxation | 2.71789794 |
10 | MP0004084_abnormal_cardiac_muscle | 2.61080625 |
11 | MP0005174_abnormal_tail_pigmentation | 2.57885042 |
12 | MP0004381_abnormal_hair_follicle | 2.50559986 |
13 | MP0000372_irregular_coat_pigmentation | 2.39687963 |
14 | MP0004215_abnormal_myocardial_fiber | 2.38575576 |
15 | MP0002837_dystrophic_cardiac_calcinosis | 2.35661432 |
16 | MP0006292_abnormal_olfactory_placode | 2.34958026 |
17 | MP0002106_abnormal_muscle_physiology | 2.23863070 |
18 | MP0005330_cardiomyopathy | 2.20326822 |
19 | MP0000015_abnormal_ear_pigmentation | 2.09085290 |
20 | MP0004233_abnormal_muscle_weight | 2.08455048 |
21 | MP0003828_pulmonary_edema | 2.03771519 |
22 | MP0005670_abnormal_white_adipose | 1.90445360 |
23 | MP0004147_increased_porphyrin_level | 1.85606113 |
24 | MP0005620_abnormal_muscle_contractility | 1.84924224 |
25 | MP0006036_abnormal_mitochondrial_physio | 1.81060996 |
26 | MP0005075_abnormal_melanosome_morpholog | 1.79021604 |
27 | MP0005369_muscle_phenotype | 1.74089412 |
28 | MP0000747_muscle_weakness | 1.70963082 |
29 | MP0002108_abnormal_muscle_morphology | 1.70794637 |
30 | MP0004484_altered_response_of | 1.67894154 |
31 | MP0003137_abnormal_impulse_conducting | 1.61741197 |
32 | MP0003724_increased_susceptibility_to | 1.61033635 |
33 | MP0001986_abnormal_taste_sensitivity | 1.60904008 |
34 | MP0002972_abnormal_cardiac_muscle | 1.60118076 |
35 | MP0004087_abnormal_muscle_fiber | 1.59704679 |
36 | MP0000759_abnormal_skeletal_muscle | 1.58867126 |
37 | MP0000733_abnormal_muscle_development | 1.53094254 |
38 | MP0002095_abnormal_skin_pigmentation | 1.49253915 |
39 | MP0004510_myositis | 1.38938093 |
40 | MP0000750_abnormal_muscle_regeneration | 1.38393514 |
41 | MP0000013_abnormal_adipose_tissue | 1.30407008 |
42 | MP0002102_abnormal_ear_morphology | 1.28405761 |
43 | MP0008775_abnormal_heart_ventricle | 1.25056722 |
44 | MP0003880_abnormal_central_pattern | 1.22748806 |
45 | MP0009785_altered_susceptibility_to | 1.22253537 |
46 | MP0000049_abnormal_middle_ear | 1.19741163 |
47 | MP0001661_extended_life_span | 1.19154143 |
48 | MP0010630_abnormal_cardiac_muscle | 1.15805103 |
49 | MP0002638_abnormal_pupillary_reflex | 1.14044676 |
50 | MP0004130_abnormal_muscle_cell | 1.13870404 |
51 | MP0004142_abnormal_muscle_tone | 1.11787523 |
52 | MP0005385_cardiovascular_system_phenoty | 1.11560315 |
53 | MP0001544_abnormal_cardiovascular_syste | 1.11560315 |
54 | MP0002148_abnormal_hypersensitivity_rea | 1.10017268 |
55 | MP0003221_abnormal_cardiomyocyte_apopto | 1.06414870 |
56 | MP0002971_abnormal_brown_adipose | 1.05869944 |
57 | MP0002269_muscular_atrophy | 1.05388632 |
58 | MP0005666_abnormal_adipose_tissue | 1.04376490 |
59 | MP0008260_abnormal_autophagy | 1.02735736 |
60 | MP0005671_abnormal_response_to | 1.01993797 |
61 | MP0000681_abnormal_thyroid_gland | 1.01195535 |
62 | MP0002177_abnormal_outer_ear | 1.00870829 |
63 | MP0005451_abnormal_body_composition | 1.00108013 |
64 | MP0002127_abnormal_cardiovascular_syste | 0.99875356 |
65 | MP0006035_abnormal_mitochondrial_morpho | 0.98964041 |
66 | MP0003567_abnormal_fetal_cardiomyocyte | 0.98578746 |
67 | MP0001835_abnormal_antigen_presentation | 0.98202974 |
68 | MP0002938_white_spotting | 0.97089162 |
69 | MP0004085_abnormal_heartbeat | 0.96736323 |
70 | MP0003763_abnormal_thymus_physiology | 0.95513515 |
71 | MP0002332_abnormal_exercise_endurance | 0.94449706 |
72 | MP0004270_analgesia | 0.93915589 |
73 | MP0002249_abnormal_larynx_morphology | 0.91630034 |
74 | MP0002876_abnormal_thyroid_physiology | 0.89885634 |
75 | MP0005171_absent_coat_pigmentation | 0.89524546 |
76 | MP0005375_adipose_tissue_phenotype | 0.88869294 |
77 | MP0000266_abnormal_heart_morphology | 0.86136262 |
78 | MP0000685_abnormal_immune_system | 0.85811121 |
79 | MP0006138_congestive_heart_failure | 0.84854407 |
80 | MP0001853_heart_inflammation | 0.82163837 |
81 | MP0005025_abnormal_response_to | 0.80742592 |
82 | MP0005165_increased_susceptibility_to | 0.80628282 |
83 | MP0000343_altered_response_to | 0.80504429 |
84 | MP0002396_abnormal_hematopoietic_system | 0.80453552 |
85 | MP0003950_abnormal_plasma_membrane | 0.79973294 |
86 | MP0009780_abnormal_chondrocyte_physiolo | 0.76227760 |
87 | MP0000003_abnormal_adipose_tissue | 0.74854079 |
88 | MP0003045_fibrosis | 0.74034211 |
89 | MP0002132_abnormal_respiratory_system | 0.73872619 |
90 | MP0000490_abnormal_crypts_of | 0.73091727 |
91 | MP0000465_gastrointestinal_hemorrhage | 0.70615637 |
92 | MP0002009_preneoplasia | 0.69800345 |
93 | MP0001905_abnormal_dopamine_level | 0.69062818 |
94 | MP0004185_abnormal_adipocyte_glucose | 0.66688639 |
95 | MP0002933_joint_inflammation | 0.65213894 |
96 | MP0008058_abnormal_DNA_repair | 0.64173412 |
97 | MP0000566_synostosis | 0.63593942 |
98 | MP0002751_abnormal_autonomic_nervous | 0.61921814 |
99 | MP0006276_abnormal_autonomic_nervous | 0.61364130 |
100 | MP0002128_abnormal_blood_circulation | 0.61059962 |
101 | MP0000631_abnormal_neuroendocrine_gland | 0.60897989 |
102 | MP0000230_abnormal_systemic_arterial | 0.60328568 |
103 | MP0008569_lethality_at_weaning | 0.59209963 |
104 | MP0003938_abnormal_ear_development | 0.59123054 |
105 | MP0003879_abnormal_hair_cell | 0.58507018 |
106 | MP0000026_abnormal_inner_ear | 0.57626004 |
107 | MP0003315_abnormal_perineum_morphology | 0.57613653 |
108 | MP0002277_abnormal_respiratory_mucosa | 0.57301194 |
109 | MP0009333_abnormal_splenocyte_physiolog | 0.56861181 |
110 | MP0001299_abnormal_eye_distance/ | 0.56819049 |
111 | MP0005266_abnormal_metabolism | 0.56116743 |
112 | MP0009250_abnormal_appendicular_skeleto | 0.54534760 |
113 | MP0005000_abnormal_immune_tolerance | 0.53278861 |
114 | MP0002723_abnormal_immune_serum | 0.53159019 |
115 | MP0010368_abnormal_lymphatic_system | 0.52985648 |
116 | MP0005595_abnormal_vascular_smooth | 0.52480518 |
117 | MP0002822_catalepsy | 0.51840499 |
118 | MP0002420_abnormal_adaptive_immunity | 0.48781126 |
119 | MP0008995_early_reproductive_senescence | 0.47726858 |
120 | MP0002078_abnormal_glucose_homeostasis | 0.44191377 |
121 | MP0010030_abnormal_orbit_morphology | 0.41406347 |
122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.35264571 |
123 | MP0005334_abnormal_fat_pad | 0.35253332 |
124 | MP0005167_abnormal_blood-brain_barrier | 0.34162492 |
125 | MP0009115_abnormal_fat_cell | 0.32933451 |
126 | MP0005535_abnormal_body_temperature | 0.32003705 |
127 | MP0003656_abnormal_erythrocyte_physiolo | 0.31242738 |
128 | MP0003279_aneurysm | 0.30388818 |
129 | MP0005187_abnormal_penis_morphology | 0.30178190 |
130 | MP0005452_abnormal_adipose_tissue | 0.29930600 |
131 | MP0003948_abnormal_gas_homeostasis | 0.28320703 |
132 | MP0005376_homeostasis/metabolism_phenot | 0.28318678 |
133 | MP0000767_abnormal_smooth_muscle | 0.28227874 |
134 | MP0000762_abnormal_tongue_morphology | 0.26156226 |
135 | MP0001984_abnormal_olfaction | 0.25038476 |
136 | MP0002234_abnormal_pharynx_morphology | 0.24655976 |
137 | MP0009672_abnormal_birth_weight | 0.24199994 |
138 | MP0004134_abnormal_chest_morphology | 0.24119666 |
139 | MP0001879_abnormal_lymphatic_vessel | 0.23785524 |
140 | MP0004924_abnormal_behavior | 0.23018150 |
141 | MP0005386_behavior/neurological_phenoty | 0.23018150 |
142 | MP0004043_abnormal_pH_regulation | 0.22058821 |
143 | MP0009384_cardiac_valve_regurgitation | 0.20860741 |
144 | MP0002114_abnormal_axial_skeleton | 0.20161759 |
145 | MP0005319_abnormal_enzyme/_coenzyme | 0.19713573 |
146 | MP0000579_abnormal_nail_morphology | 0.18919093 |
147 | MP0005332_abnormal_amino_acid | 0.17827242 |
148 | MP0003941_abnormal_skin_development | 0.16177332 |
149 | MP0002896_abnormal_bone_mineralization | 0.15738763 |
150 | MP0001784_abnormal_fluid_regulation | 0.15153316 |
151 | MP0002925_abnormal_cardiovascular_devel | 0.14816972 |
152 | MP0001614_abnormal_blood_vessel | 0.14557586 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Bundle branch block (HP:0011710) | 5.47974011 |
2 | Muscle hypertrophy of the lower extremities (HP:0008968) | 5.32577954 |
3 | Calf muscle hypertrophy (HP:0008981) | 5.25938087 |
4 | Type I transferrin isoform profile (HP:0003642) | 4.71068699 |
5 | Asymmetric septal hypertrophy (HP:0001670) | 4.46909666 |
6 | Nonprogressive disorder (HP:0003680) | 4.39455368 |
7 | Exercise-induced myalgia (HP:0003738) | 4.26458208 |
8 | Reduced antithrombin III activity (HP:0001976) | 4.12531026 |
9 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.06493944 |
10 | Subaortic stenosis (HP:0001682) | 4.06493944 |
11 | Muscle fiber inclusion bodies (HP:0100299) | 4.01550204 |
12 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.97620593 |
13 | Exercise-induced muscle cramps (HP:0003710) | 3.88392761 |
14 | Ulnar deviation of the wrist (HP:0003049) | 3.87996574 |
15 | Hepatocellular necrosis (HP:0001404) | 3.83467795 |
16 | Nemaline bodies (HP:0003798) | 3.82587202 |
17 | Difficulty running (HP:0009046) | 3.80350194 |
18 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.67601419 |
19 | Acute necrotizing encephalopathy (HP:0006965) | 3.63533915 |
20 | Mitochondrial inheritance (HP:0001427) | 3.62922803 |
21 | Sudden death (HP:0001699) | 3.57000202 |
22 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.55786803 |
23 | EMG: neuropathic changes (HP:0003445) | 3.53204806 |
24 | Increased hepatocellular lipid droplets (HP:0006565) | 3.50592103 |
25 | Hepatic necrosis (HP:0002605) | 3.48643833 |
26 | Increased connective tissue (HP:0009025) | 3.47953480 |
27 | Hypothermia (HP:0002045) | 3.43154962 |
28 | Abnormality of the calf musculature (HP:0001430) | 3.40946305 |
29 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.36269972 |
30 | Heart block (HP:0012722) | 3.36002401 |
31 | Type 2 muscle fiber atrophy (HP:0003554) | 3.35250241 |
32 | Increased variability in muscle fiber diameter (HP:0003557) | 3.29242096 |
33 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.21612827 |
34 | Abnormal protein glycosylation (HP:0012346) | 3.20450876 |
35 | Abnormal glycosylation (HP:0012345) | 3.20450876 |
36 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 3.20450876 |
37 | Abnormal protein N-linked glycosylation (HP:0012347) | 3.20450876 |
38 | Ventricular tachycardia (HP:0004756) | 3.18095353 |
39 | Abnormal atrioventricular conduction (HP:0005150) | 3.16587591 |
40 | Absent phalangeal crease (HP:0006109) | 3.16418367 |
41 | Increased CSF lactate (HP:0002490) | 3.15879015 |
42 | Lipid accumulation in hepatocytes (HP:0006561) | 3.15062393 |
43 | Exercise intolerance (HP:0003546) | 3.14614811 |
44 | Frequent falls (HP:0002359) | 3.13789354 |
45 | Atrial fibrillation (HP:0005110) | 3.08722505 |
46 | Generalized muscle weakness (HP:0003324) | 3.07738836 |
47 | Lipoatrophy (HP:0100578) | 3.07235136 |
48 | Distal arthrogryposis (HP:0005684) | 3.03807762 |
49 | Ventricular arrhythmia (HP:0004308) | 3.03605359 |
50 | Abnormal number of erythroid precursors (HP:0012131) | 3.01724471 |
51 | Renal Fanconi syndrome (HP:0001994) | 3.00680664 |
52 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.00397646 |
53 | Increased intramyocellular lipid droplets (HP:0012240) | 2.97828260 |
54 | Muscle fiber atrophy (HP:0100295) | 2.96711434 |
55 | Deformed tarsal bones (HP:0008119) | 2.90961858 |
56 | Supraventricular tachycardia (HP:0004755) | 2.87280705 |
57 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.86656025 |
58 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.86656025 |
59 | EMG: myopathic abnormalities (HP:0003458) | 2.86312260 |
60 | Progressive macrocephaly (HP:0004481) | 2.85329504 |
61 | Primary atrial arrhythmia (HP:0001692) | 2.84581961 |
62 | Malignant hyperthermia (HP:0002047) | 2.83103332 |
63 | Weak cry (HP:0001612) | 2.82605729 |
64 | Supraventricular arrhythmia (HP:0005115) | 2.75141920 |
65 | Right ventricular cardiomyopathy (HP:0011663) | 2.73270472 |
66 | 3-Methylglutaconic aciduria (HP:0003535) | 2.72458851 |
67 | Type 1 muscle fiber predominance (HP:0003803) | 2.71899099 |
68 | Gowers sign (HP:0003391) | 2.70175997 |
69 | Optic disc pallor (HP:0000543) | 2.66745697 |
70 | Acute encephalopathy (HP:0006846) | 2.66352465 |
71 | Thyroid-stimulating hormone excess (HP:0002925) | 2.65770924 |
72 | Dilated cardiomyopathy (HP:0001644) | 2.65254207 |
73 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.62781564 |
74 | Muscle fiber splitting (HP:0003555) | 2.61600804 |
75 | Increased muscle lipid content (HP:0009058) | 2.61259129 |
76 | Abnormal finger flexion creases (HP:0006143) | 2.59466020 |
77 | Exertional dyspnea (HP:0002875) | 2.58559250 |
78 | Respiratory difficulties (HP:0002880) | 2.54998188 |
79 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.54418821 |
80 | Microvesicular hepatic steatosis (HP:0001414) | 2.49778228 |
81 | Myoglobinuria (HP:0002913) | 2.46778750 |
82 | Fetal akinesia sequence (HP:0001989) | 2.46142049 |
83 | Rhabdomyolysis (HP:0003201) | 2.42194540 |
84 | Increased serum lactate (HP:0002151) | 2.41046720 |
85 | Scapular winging (HP:0003691) | 2.37940331 |
86 | Lactic acidosis (HP:0003128) | 2.36747572 |
87 | Atrioventricular block (HP:0001678) | 2.35448829 |
88 | Muscular dystrophy (HP:0003560) | 2.32426974 |
89 | Severe visual impairment (HP:0001141) | 2.31941152 |
90 | Fatigable weakness (HP:0003473) | 2.31448769 |
91 | Abnormality of the neuromuscular junction (HP:0003398) | 2.31448769 |
92 | Abnormality of the foot musculature (HP:0001436) | 2.31167140 |
93 | Neck muscle weakness (HP:0000467) | 2.28048187 |
94 | Distal lower limb amyotrophy (HP:0008944) | 2.26929017 |
95 | Ventricular fibrillation (HP:0001663) | 2.23917201 |
96 | Reticulocytopenia (HP:0001896) | 2.23860622 |
97 | Limb-girdle muscle atrophy (HP:0003797) | 2.22773929 |
98 | Abnormality of the axillary hair (HP:0100134) | 2.21095235 |
99 | Abnormality of secondary sexual hair (HP:0009888) | 2.21095235 |
100 | Myopathic facies (HP:0002058) | 2.20873275 |
101 | Attenuation of retinal blood vessels (HP:0007843) | 2.20553270 |
102 | Myotonia (HP:0002486) | 2.18816575 |
103 | Ragged-red muscle fibers (HP:0003200) | 2.11890573 |
104 | Aplastic anemia (HP:0001915) | 2.10812758 |
105 | Popliteal pterygium (HP:0009756) | 2.09214783 |
106 | Respiratory failure (HP:0002878) | 2.09155392 |
107 | Muscle stiffness (HP:0003552) | 2.06010897 |
108 | Abnormality of alanine metabolism (HP:0010916) | 2.05735992 |
109 | Hyperalaninemia (HP:0003348) | 2.05735992 |
110 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.05735992 |
111 | Prolonged QT interval (HP:0001657) | 2.05651742 |
112 | Foot dorsiflexor weakness (HP:0009027) | 2.05568714 |
113 | Areflexia of lower limbs (HP:0002522) | 2.05285082 |
114 | Difficulty climbing stairs (HP:0003551) | 2.02395523 |
115 | Hip contracture (HP:0003273) | 2.02281017 |
116 | Round ear (HP:0100830) | 2.01863022 |
117 | Rimmed vacuoles (HP:0003805) | 2.01125604 |
118 | Proximal amyotrophy (HP:0007126) | 2.00695757 |
119 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.98131075 |
120 | Hyporeflexia of lower limbs (HP:0002600) | 1.96694132 |
121 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.95908634 |
122 | Slender build (HP:0001533) | 1.94253735 |
123 | Palpitations (HP:0001962) | 1.93260246 |
124 | Cerebral edema (HP:0002181) | 1.92700677 |
125 | Hyperkalemia (HP:0002153) | 1.90654224 |
126 | Spinal rigidity (HP:0003306) | 1.89861846 |
127 | Distal lower limb muscle weakness (HP:0009053) | 1.86260968 |
128 | Waddling gait (HP:0002515) | 1.85812195 |
129 | True hermaphroditism (HP:0010459) | 1.85562917 |
130 | Abnormality of renal resorption (HP:0011038) | 1.85175028 |
131 | Left ventricular hypertrophy (HP:0001712) | 1.80815818 |
132 | Progressive muscle weakness (HP:0003323) | 1.80771454 |
133 | Oligomenorrhea (HP:0000876) | 1.80542487 |
134 | Steppage gait (HP:0003376) | 1.79784132 |
135 | Syncope (HP:0001279) | 1.78814144 |
136 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.76204979 |
137 | Abnormality of the calcaneus (HP:0008364) | 1.75893890 |
138 | Bulbar palsy (HP:0001283) | 1.71029201 |
139 | Toxemia of pregnancy (HP:0100603) | 1.70787606 |
140 | Abnormal EKG (HP:0003115) | 1.69022152 |
141 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.68410572 |
142 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.68193730 |
143 | Calcaneovalgus deformity (HP:0001848) | 1.67842393 |
144 | Lower limb amyotrophy (HP:0007210) | 1.66141623 |
145 | Palmoplantar keratoderma (HP:0000982) | 1.64431793 |
146 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.60185773 |
147 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.60185773 |
148 | Limb-girdle muscle weakness (HP:0003325) | 1.58890137 |
149 | Aplasia of the musculature (HP:0100854) | 1.55568742 |
150 | Facial diplegia (HP:0001349) | 1.50094682 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TNIK | 6.21320874 |
2 | MUSK | 5.96529978 |
3 | OBSCN | 4.85922015 |
4 | CASK | 2.96008444 |
5 | NME2 | 2.90145550 |
6 | STK16 | 2.86407700 |
7 | NLK | 2.62035738 |
8 | MKNK2 | 2.40321428 |
9 | PHKG1 | 2.12990262 |
10 | PHKG2 | 2.12990262 |
11 | MYLK | 2.10740189 |
12 | EIF2AK3 | 1.85671133 |
13 | ZAK | 1.73192407 |
14 | MKNK1 | 1.62700606 |
15 | TEC | 1.56010438 |
16 | LIMK1 | 1.50682175 |
17 | PDK2 | 1.47881081 |
18 | STK24 | 1.46276318 |
19 | KIT | 1.45577932 |
20 | TIE1 | 1.42778242 |
21 | SRPK1 | 1.36672007 |
22 | PIK3CA | 1.35952218 |
23 | CAMK1 | 1.33709402 |
24 | EIF2AK2 | 1.33541979 |
25 | PIK3CG | 1.24978777 |
26 | MARK1 | 1.18223960 |
27 | IRAK4 | 1.17152540 |
28 | CAMKK2 | 1.16916465 |
29 | MAP2K7 | 1.16172828 |
30 | CLK1 | 1.14914362 |
31 | GRK7 | 1.13391849 |
32 | TLK1 | 1.11453729 |
33 | PINK1 | 1.11219885 |
34 | NME1 | 1.11171228 |
35 | ADRBK2 | 1.10748784 |
36 | MAPK13 | 1.07271476 |
37 | CDK19 | 1.05891871 |
38 | MAP2K3 | 1.05649476 |
39 | VRK1 | 1.03704228 |
40 | NEK1 | 1.01497929 |
41 | NEK9 | 0.99959215 |
42 | FES | 0.99202245 |
43 | TRPM7 | 0.96402594 |
44 | TTN | 0.96325420 |
45 | MAPKAPK5 | 0.94979979 |
46 | BRSK2 | 0.93740345 |
47 | IRAK3 | 0.92585972 |
48 | YES1 | 0.92118166 |
49 | CCNB1 | 0.86921848 |
50 | PIM2 | 0.85945434 |
51 | PRKAA1 | 0.85428555 |
52 | ROCK1 | 0.81254161 |
53 | MAP2K4 | 0.81089062 |
54 | FLT3 | 0.80802165 |
55 | BCKDK | 0.79900918 |
56 | WEE1 | 0.78806047 |
57 | MAPK12 | 0.77756781 |
58 | BTK | 0.77735456 |
59 | PRKAA2 | 0.75806701 |
60 | ERBB3 | 0.75686329 |
61 | TXK | 0.75051140 |
62 | MAP3K12 | 0.74094004 |
63 | MAPKAPK3 | 0.73661314 |
64 | BLK | 0.70614788 |
65 | PAK3 | 0.67758903 |
66 | BMPR1B | 0.66972353 |
67 | MAPK7 | 0.64588558 |
68 | MOS | 0.61408739 |
69 | GRK1 | 0.60137514 |
70 | EEF2K | 0.60098175 |
71 | PRKG2 | 0.59244003 |
72 | IKBKB | 0.58471748 |
73 | PRKD1 | 0.58156713 |
74 | MAP3K7 | 0.57492676 |
75 | CAMK2D | 0.56484997 |
76 | KDR | 0.56348574 |
77 | CDK3 | 0.56324849 |
78 | AKT2 | 0.54227090 |
79 | TGFBR2 | 0.52758788 |
80 | MAP2K6 | 0.52717396 |
81 | MAP2K1 | 0.50719603 |
82 | PRKD2 | 0.50577207 |
83 | MAPK4 | 0.50401122 |
84 | STK39 | 0.49317505 |
85 | DYRK3 | 0.47881676 |
86 | IKBKE | 0.47032083 |
87 | MAP3K5 | 0.43823665 |
88 | MAPK15 | 0.43521322 |
89 | EPHA3 | 0.43251433 |
90 | ILK | 0.43117719 |
91 | IRAK1 | 0.42907646 |
92 | LYN | 0.40721633 |
93 | BMPR2 | 0.40663367 |
94 | RPS6KA5 | 0.39704949 |
95 | PRKG1 | 0.39103787 |
96 | RIPK1 | 0.38974993 |
97 | MAP3K6 | 0.38418305 |
98 | CSNK1G1 | 0.37317991 |
99 | DMPK | 0.36992400 |
100 | INSRR | 0.36754723 |
101 | ROCK2 | 0.36457823 |
102 | DYRK1B | 0.36165735 |
103 | TRIB3 | 0.35527796 |
104 | PKN1 | 0.35498870 |
105 | MATK | 0.34294289 |
106 | CDK8 | 0.34074997 |
107 | LATS2 | 0.33406272 |
108 | CAMK4 | 0.33086053 |
109 | MAP3K13 | 0.32640764 |
110 | PRKACG | 0.32555234 |
111 | NEK6 | 0.31230845 |
112 | PRKACA | 0.31137041 |
113 | SGK3 | 0.30694818 |
114 | SYK | 0.30508498 |
115 | STK38L | 0.30241073 |
116 | TNK2 | 0.29601803 |
117 | RPS6KA3 | 0.29514957 |
118 | MAPK11 | 0.29408519 |
119 | CAMK2B | 0.28916202 |
120 | TBK1 | 0.28728233 |
121 | IRAK2 | 0.28666474 |
122 | PRKACB | 0.28004087 |
123 | SGK2 | 0.27534214 |
124 | CAMK2A | 0.27073703 |
125 | CSF1R | 0.26766442 |
126 | HIPK2 | 0.26599614 |
127 | RPS6KA1 | 0.26476896 |
128 | CSNK2A1 | 0.25838453 |
129 | KSR2 | 0.25107977 |
130 | ACVR1B | 0.24392488 |
131 | MAP3K14 | 0.24282986 |
132 | RPS6KL1 | 0.23538011 |
133 | RPS6KC1 | 0.23538011 |
134 | CAMK2G | 0.23490392 |
135 | PDPK1 | 0.23373682 |
136 | DYRK2 | 0.23157986 |
137 | PRKCE | 0.22697645 |
138 | RPS6KA6 | 0.20472256 |
139 | MAPK10 | 0.18717450 |
140 | PDK1 | 0.18264346 |
141 | CDC42BPA | 0.17967732 |
142 | STK11 | 0.17825244 |
143 | RAF1 | 0.16171340 |
144 | LATS1 | 0.15732369 |
145 | SGK1 | 0.15445424 |
146 | STK4 | 0.15172292 |
147 | EPHB1 | 0.14475941 |
148 | PKN2 | 0.13382427 |
149 | RPS6KB1 | 0.11596449 |
150 | MARK2 | 0.11565385 |
151 | MARK3 | 0.11031045 |
152 | MTOR | 0.09994181 |
153 | WNK1 | 0.09952227 |
154 | FGFR3 | 0.07028600 |
155 | SGK223 | 0.05645292 |
156 | SGK494 | 0.05645292 |
157 | PRKDC | 0.04618617 |
158 | ZAP70 | 0.04197930 |
159 | DAPK3 | 0.03516099 |
160 | PTK2B | 0.03440444 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome_Homo sapiens_hsa03010 | 4.39025717 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.13239672 |
3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.95117895 |
4 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.87008312 |
5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.63570736 |
6 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.42024867 |
7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.68519591 |
8 | Protein export_Homo sapiens_hsa03060 | 2.54197035 |
9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 2.53992425 |
10 | Huntingtons disease_Homo sapiens_hsa05016 | 2.50298393 |
11 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.45571204 |
12 | DNA replication_Homo sapiens_hsa03030 | 2.37120538 |
13 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.34424439 |
14 | Homologous recombination_Homo sapiens_hsa03440 | 2.14360596 |
15 | RNA polymerase_Homo sapiens_hsa03020 | 2.11916088 |
16 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.07141371 |
17 | Carbon metabolism_Homo sapiens_hsa01200 | 2.01432885 |
18 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.94818085 |
19 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.84792952 |
20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.76641471 |
21 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.71326255 |
22 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.70866122 |
23 | Proteasome_Homo sapiens_hsa03050 | 1.70865566 |
24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.66649125 |
25 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.59750530 |
26 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.58155060 |
27 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.56123894 |
28 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.54017488 |
29 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.48292707 |
30 | Mismatch repair_Homo sapiens_hsa03430 | 1.48097292 |
31 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.46305847 |
32 | Purine metabolism_Homo sapiens_hsa00230 | 1.45821172 |
33 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.45154021 |
34 | Insulin resistance_Homo sapiens_hsa04931 | 1.45044497 |
35 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40140032 |
36 | Base excision repair_Homo sapiens_hsa03410 | 1.34499588 |
37 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.28270120 |
38 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.28209754 |
39 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.28133725 |
40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.26833511 |
41 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.26650228 |
42 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.21441675 |
43 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.19708595 |
44 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.19581256 |
45 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.18667492 |
46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.18084837 |
47 | Phototransduction_Homo sapiens_hsa04744 | 1.17376805 |
48 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.16410370 |
49 | Basal transcription factors_Homo sapiens_hsa03022 | 1.13461459 |
50 | Renin secretion_Homo sapiens_hsa04924 | 1.13138105 |
51 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.12921966 |
52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.12056485 |
53 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.09434856 |
54 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.09324466 |
55 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.09100274 |
56 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.08737333 |
57 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 1.07047691 |
58 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.03334238 |
59 | RNA degradation_Homo sapiens_hsa03018 | 0.98977201 |
60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.98185570 |
61 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.96735738 |
62 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.95124124 |
63 | Allograft rejection_Homo sapiens_hsa05330 | 0.93886013 |
64 | Asthma_Homo sapiens_hsa05310 | 0.92574702 |
65 | Spliceosome_Homo sapiens_hsa03040 | 0.91583769 |
66 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.89305897 |
67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88455560 |
68 | Tight junction_Homo sapiens_hsa04530 | 0.88441874 |
69 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.88149650 |
70 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87554392 |
71 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.87224978 |
72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86839694 |
73 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.84770249 |
74 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.81223306 |
75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.81181608 |
76 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80521186 |
77 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.75319693 |
78 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.75156659 |
79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.74829343 |
80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74629687 |
81 | Measles_Homo sapiens_hsa05162 | 0.73817293 |
82 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.71760306 |
83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.71685497 |
84 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.70553256 |
85 | Focal adhesion_Homo sapiens_hsa04510 | 0.69687892 |
86 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69076526 |
87 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67925786 |
88 | Insulin secretion_Homo sapiens_hsa04911 | 0.66794781 |
89 | Metabolic pathways_Homo sapiens_hsa01100 | 0.66309303 |
90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.65931460 |
91 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.64945134 |
92 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64112792 |
93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63087213 |
94 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.62233644 |
95 | Circadian entrainment_Homo sapiens_hsa04713 | 0.60949960 |
96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.60401215 |
97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58975231 |
98 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.56810357 |
99 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.56689965 |
100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.56274505 |
101 | Malaria_Homo sapiens_hsa05144 | 0.56055392 |
102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.55497096 |
103 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55445745 |
104 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53078781 |
105 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.52754220 |
106 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.51147316 |
107 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.50460169 |
108 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.49881132 |
109 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.47469871 |
110 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.47001042 |
111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.44761288 |
112 | Leishmaniasis_Homo sapiens_hsa05140 | 0.43795832 |
113 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.43419039 |
114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.42454149 |
115 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.41282897 |
116 | Salivary secretion_Homo sapiens_hsa04970 | 0.41018705 |
117 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.40908961 |
118 | Olfactory transduction_Homo sapiens_hsa04740 | 0.40796214 |
119 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39822882 |
120 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.39725548 |
121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38654431 |
122 | Long-term potentiation_Homo sapiens_hsa04720 | 0.37887650 |
123 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.37489352 |
124 | Adherens junction_Homo sapiens_hsa04520 | 0.37142640 |
125 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36988058 |
126 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.35089223 |
127 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34926369 |
128 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34480095 |
129 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.34405184 |
130 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33655609 |
131 | Taste transduction_Homo sapiens_hsa04742 | 0.33100405 |
132 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.32637046 |
133 | Lysine degradation_Homo sapiens_hsa00310 | 0.32333417 |
134 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.32107471 |
135 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.31757571 |
136 | Peroxisome_Homo sapiens_hsa04146 | 0.31344605 |
137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31247913 |
138 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.30099502 |
139 | Viral myocarditis_Homo sapiens_hsa05416 | 0.28457507 |
140 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27666644 |
141 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.26748807 |
142 | Bile secretion_Homo sapiens_hsa04976 | 0.25557758 |
143 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.25504303 |
144 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24339583 |
145 | Platelet activation_Homo sapiens_hsa04611 | 0.23524992 |
146 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.22830484 |
147 | Gap junction_Homo sapiens_hsa04540 | 0.22030053 |
148 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.21083875 |
149 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.21044492 |
150 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.20961024 |
151 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.20349309 |
152 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.18796283 |
153 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.18653702 |
154 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.18383632 |
155 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.18356205 |
156 | ABC transporters_Homo sapiens_hsa02010 | 0.18078403 |
157 | Pertussis_Homo sapiens_hsa05133 | 0.17636693 |
158 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.17298936 |
159 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.16991828 |
160 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.16322549 |
161 | Histidine metabolism_Homo sapiens_hsa00340 | 0.15413715 |
162 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.14436174 |
163 | Amoebiasis_Homo sapiens_hsa05146 | 0.14077944 |
164 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.13983850 |
165 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.13943753 |
166 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.13934071 |
167 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.13814650 |
168 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.11202810 |
169 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.09944683 |
170 | Melanogenesis_Homo sapiens_hsa04916 | 0.07661107 |